Skip to Content

M 36 (Methylphenidate hydrochloride extended-release 36 mg)

Pill imprint M 36 has been identified as Methylphenidate hydrochloride extended-release 36 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; severe mood dysregulation; fatigue; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 36 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Methylphenidate hydrochloride extended-release 36 mg M 36  Front
Methylphenidate hydrochloride extended-release 36 mg M 36  Back
Methylphenidate hydrochloride extended-release 36 mg M 36
Discount Card Promo
Methylphenidate hydrochloride extended-release
Imprint:
M 36
Strength:
36 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Mallinckrodt, Inc.
National Drug Code (NDC):
00406-0136
Inactive Ingredients:
microcrystalline cellulose
ethylcelluloses
hydroxypropyl cellulose (type h)
hypromellose 2910 (6 mPa.s)
ferric oxide red
ferrosoferric oxide
magnesium stearate
medium-chain triglycerides
oleic acid
polyethylene glycol
polyvinyl alcohol
propylene glycol
shellac
silicon dioxide
magnesium silicate
titanium dioxide
triacetin

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide